Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Mar;35(3):1723-1731.
doi: 10.1007/s00330-024-11343-w. Epub 2025 Feb 28.

Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy

Affiliations
Multicenter Study

Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy

Benedikt M Schaarschmidt et al. Eur Radiol. 2025 Mar.

Abstract

Objective: To evaluate the success and complications of thermal ablation (TA) based on the voluntary, prospective registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) with 303 participating centers from Germany, Austria, and Switzerland.

Materials and methods: Registry data from 2018 until 2023 of 1102 patients with small renal tumors (age: 72.5 ± 11.6 years; female: 33.6%, 370/1102) were analyzed. Hospitals with ≥ 20 TAs were considered high-volume centers. Technical success and complication rates between different parameters were compared using the chi-square or Fisher's exact test, p < 0.05 was considered statistically significant.

Results: Patients were most frequently treated with radiofrequency ablation (RFA, 43.6%, 481/1102), then microwave ablation (MWA, 41.9%, 462/1102) or cryoablation (13.3%, 147/1102). Technical success for heat-based TA (RFA&MWA) was 94.3% (893/947), for cryoablation 97.3% (143/147). RFA&MWA was significantly more successful in lesions ≤ 3 cm (96.1%, 567/590) compared to 3-4 cm lesions (89.8%, 97/108; p = 0.005). In patients treated with cryoablation, no significant differences between sizes could be found (≤ 3 cm: 97.9%, 94/96; 3-4 cm: 85.7%, 12/14; p = 0.078). Complication rate was significantly higher in RFA&MWA of lesions 3-4 cm compared to ≤ 3 cm (≤ 3 cm: 3.9%, 23/590; 3-4 cm: 11.1%, 12/108, p = 0.002), while no significant differences were seen regarding cryoablation (≤ 3 cm: 1.0%, 1/96; 3-4 cm: 0.0%, 0/14; p = 1.000).

Conclusions: In this exploratory analysis of the DeGIR registry, percutaneous TA of small renal masses is technically feasible with low complication rates. Heat-based TAs seem to have lower success rates and higher complication rates in larger tumors. Cryoablation could potentially be a safe alternative for 3- to 4-cm-sized tumors.

Key points: Question How effective is renal thermal ablation (TA) in terms of treatment success and complication rates? Findings In contrast to cryoablation, heat-based thermal ablation has lower success and higher complication rates in tumors measuring 3-4 cm compared to tumors < 3 cm. Clinical relevance Thermal ablation is not influenced by the need for additional techniques such as cooling, protective organ displacement, or temporary vessel occlusion. For small renal tumors, TA is an effective and safe treatment option. Cryoablation could be beneficial in larger tumors.

Keywords: Cryoablation; Kidney; Microwave ablation; Radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Benedikt M. Schaarschmidt. Conflict of interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: No complex statistical methods were necessary for this paper. Informed consent: Written informed consent was waived by the Institutional Review Board. Ethical approval: Institutional Review Board approval was obtained from the local ethics committee of the University Duisburg-Essen (Approval number: 23-11352-BO, date of approval: 25.07.2023). Study subjects or cohorts overlap: No study subjects or cohorts have been previously reported. Methodology: Retrospective Observational Multicenter study

Figures

Fig. 1
Fig. 1
Study flow-chart depicting the process of patient identification, patient inclusion and data analysis of the DeGIR registry
Fig. 2
Fig. 2
Use of different thermal ablation methods reported in the DeGIR registry from 2018 to 2023
Fig. 3
Fig. 3
82-year-old patient with an incidentally detected renal mass in the right kidney (A, B). As the patient received anticoagulation due to endovascular aortic repair, cryoablation with a total of three cryoablation needles was successfully performed with a satisfactory safety margin (C)

Comment in

References

    1. Bukavina L, Bensalah K, Bray F et al (2022) Epidemiology of renal cell carcinoma: 2022 update. Eur Urol 82:529–542. 10.1016/j.eururo.2022.08.019 - DOI - PubMed
    1. Capitanio U, Bedke J, Albiges L et al (2023) A renewal of the TNM staging system for patients with renal cancer to comply with current decision-making: proposal from the European Association of Urology Guidelines Panel. Eur Urol 83:3–5. 10.1016/j.eururo.2022.09.026 - DOI - PubMed
    1. Campbell SC, Clark PE, Chang SS et al (2021) Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: Part I. J Urol 206:199–208. 10.1097/JU.0000000000001911 - DOI - PubMed
    1. Uroweb (2024) EAU guidelines on renal cell cancer (update 2024). European Association of Urology. https://uroweb.org/guidelines/renal-cell-carcinoma/chapter/introduction. Accessed 11 May 2024
    1. Hu X, Shao Y-X, Wang Y et al (2019) Partial nephrectomy versus ablative therapies for cT1a renal masses: a systematic review and meta-analysis. Eur J Surg Oncol 45:1527–1535. 10.1016/j.ejso.2019.05.010 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources